METHODS RESPECTIVELY FOR PRODUCING MESODERMAL CELLS AND HEMATOPOIETIC CELLS
- 专利权人:
- 发明人:
- Tatsutoshi Nakahata,Megumu Saito,Akira Niwa,Yoshinori Sugimine
- 申请号：
- US15320722
- 公开号：
- US20170130202A1
- 申请日:
- 2015.06.24
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention aims to provide a novel method for producing mesodermal cells, and a graft material containing mesodermal cells obtained by this method. The present invention also aims to provide a novel method for producing hematopoietic cells, and a therapeutic agent for blood diseases containing a hematopoietic cell obtained by the method. These objects can be achieved by providing a novel method for producing mesodermal cells and/or hematopoietic cells, which method includes culturing pluripotent stem cells in contact with a three-dimensional support.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION COMPRISING STEM CELLS TREATED WITH DNA METHYLTRANSFERASE OR CULTURE THEREOF FOR PREVENTION AND TREATMENT OF IMMUNE DISEASES AND INFLAMMATORY DISEASES
- Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune diseases and inflammatory diseases
- METHODS FOR CULTURING MESENCHYMAL STEM CELL DERIVED FROM PLACENTA AMNIOTIC MEMBRANE AND COMPOSITIONS COMPRISING MESENCHYMAL STEM CELL FOR REPAIRING PERIPHERAL ARTERIAL DISEASE
- Preparations used to promote proliferation of neural stem cells, preparations used for prevention or treatment of diseases related to decrease in neural stem cells, preparations used to promote post-synaptic formation, prevention of diseases related to reduction of post-synaptic formation or Formulation used for treatment and screening method
- Pharmaceutical composition comprising stem cells treated with NOD2 agonist or culture thereof for prevention and treatment of immune diseases and inflammatory diseases
